Eton Pharmaceuticals Balance Sheet
NASDAQ: ETONHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Eton Pharmaceuticals financial position
At the end of fiscal 2025, Eton Pharmaceuticals reported total assets of $92.1 million, up 21.0% from a year earlier against total liabilities of $66.0 million. Shareholders' equity stood at $26.2 million, or 28.4% of assets. The company held $25.9 million in cash and equivalents against $30.6 million of debt, a net debt position of $4.6 million.
The current ratio (current assets divided by current liabilities) was 1.57, meaning short-term assets cover obligations due within a year. Debt-to-equity was 1.17.
Summary generated from market data by MetaCap's automated system. Methodology
Eton Pharmaceuticals balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 25.94M | 14.94M | 21.39M | 16.30M | 14.41M | 21.30M | 12.07M | 26.73M | 13.16M |
| Receivables | 11.76M | 5.36M | 3.41M | 1.85M | 5.47M | 48.00K | 473.00K | — | — |
| Inventory | 15.42M | 15.23M | 911.00K | 557.00K | 550.00K | 1.24M | 380.00K | — | — |
| Total Current Assets | 60.58M | 41.02M | 26.84M | 20.00M | 23.60M | 24.70M | 15.01M | 27.50M | 13.29M |
| Property, Plant & Equipment | 326.00K | 34.00K | 58.00K | 72.00K | 115.00K | 811.00K | 1.12M | 773.00K | 119.00K |
| Intangible Assets | 30.88M | 34.88M | 4.74M | 4.75M | 3.62M | 575.00K | 725.00K | — | — |
| Total Assets | 92.11M | 76.12M | 31.74M | 25.03M | 27.46M | 26.32M | 17.07M | 28.33M | 13.44M |
| Accounts Payable | 10.98M | 4.17M | 1.85M | 1.77M | 1.77M | 2.34M | 575.00K | 1.42M | 539.00K |
| Short-Term Debt | 8.79M | 0 | 5.38M | 1.03M | 1.42M | — | — | — | — |
| Total Current Liabilities | 38.49M | 19.95M | 16.24M | 6.46M | 4.56M | 3.79M | 1.96M | 2.02M | 793.00K |
| Long-Term Debt | 21.77M | 29.81M | 0 | 5.38M | 5.26M | 6.53M | 4.54M | — | — |
| Total Liabilities | 65.96M | 51.70M | 16.26M | 11.95M | 9.84M | 10.66M | 6.52M | 2.02M | 1.31M |
| Shareholders' Equity | 26.15M | 24.43M | 15.48M | 13.08M | 17.63M | 17.63M | 10.55M | 26.30M | -6.87M |
| Retained Earnings | -112.49M | -107.89M | -104.07M | -103.13M | -94.11M | -92.16M | -64.19M | -45.87M | -8.64M |
| Total Debt | 30.56M | 29.81M | 5.38M | 6.42M | 6.68M | 6.53M | 4.54M | — | — |
| Net Cash (Debt) | -4.62M | -14.88M | 16.01M | 9.89M | 7.73M | 14.76M | 7.53M | 26.73M | 13.16M |
| Shares Outstanding | 27.05M | 26.71M | 25.69M | 25.35M | 24.63M | 24.31M | 17.88M | 17.61M | 6.00M |
This table shows 9 annual periods of Eton Pharmaceuticals's balance sheet, from FY 2025 back to FY 2017, across 17 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow ETON's reporting calendar. What is a balance sheet?